Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment using a special gel with miR-665 reduces inflammation and helps hair regrow in alopecia areata.

Ethnic hair products contain different allergens than nonethnic ones, with fragrance being the most common in ethnic products.

Certain genes may be linked to autoimmune conditions in people with alopecia areata.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Certain biomarkers can help distinguish between irritant and allergic contact dermatitis.

A man got an allergic skin reaction from using superglue on a wig.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Local inflammation worsens autoimmune skin conditions by increasing antibody buildup.

Natural products like propolis are causing more skin allergies, and certain skin treatments and medications have various side effects and risks.

The Notch signaling pathway helps in mouse hair development through a noncanonical mechanism that does not rely on RBPj or transcription.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Unregulated exosome-based injections can cause severe skin reactions and scarring.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

A woman developed alopecia after her second Pfizer vaccine but regrew her hair with treatment and had no issues after a booster shot.

A new diagnostic model can help better diagnose and understand Alopecia Areata.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

A woman had a delayed allergic reaction to the blood thinner enoxaparin, treated with a steroid cream.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Dupilumab may help treat alopecia areata without needing high IgE levels.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Patch testing is crucial to reduce allergic reactions in hair loss treatments.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Using old drugs for new uses can help treat rare immune deficiencies.

Type B material, ground for 8 hours, is the most suitable and compatible for use as a soft tissue filler.